1930
Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.

Industries:

Medical
Health Diagnostics
Life Science
Pharmaceutical
Biotechnology
Medical Device
Biopharma

Program Types:

Accelerator

Program duration:

Investment Stages:

City/State:

Country:

Contact information:

mailcarbxapp@bu.edu
twitter